Concepedia

Kimberley A. Lentz

KA

35

Publications

1.8K

Citations

22

H-Index

2000

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

University of Maryland, Baltimore

Pfizer (United States)

Research Triangle Park Foundation

Kimberley A. Lentz is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2000–2022

35

Publications

35

Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor

Kevin W. Gillman, John E. Starrett, Michael F. Parker et al. · ACS Medicinal Chemistry Letters · 2010 · 183 citations

, , +19

Predicting Effect of Food on Extent of Drug Absorption Based on Physicochemical Properties

Chong‐Hui Gu, Hua Li, Jaquan K. Levons et al. · Pharmaceutical Research · 2007 · 153 citations

, , +8

Influence of Passive Permeability on Apparent P-glycoprotein Kinetics

Kimberley A. Lentz, Joseph W. Polli, Stephen A. Wring et al. · Pharmaceutical Research · 2000 · 126 citations

Increased Acyclovir Oral Bioavailability via a Bile Acid Conjugate

Sanna Tolle‐Sander, Kimberley A. Lentz, Dean Y. Maeda et al. · Molecular Pharmaceutics · 2003 · 120 citations

Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain

Walter A. Kostich, Brian D. Hamman, S. Naidu et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 118 citations · Full text

Rows per page

1–5 of 35